Tempus AI Inc (NASDAQ:TEM) reported fourth-quarter financial results after the market close on Monday. Here’s a look at the key metrics from the quarter. Q4 Earnings: Tempus AI reported fourth-quarter ...
Tempus AI, Inc. (NASDAQ:TEM) is one of the best healthcare AI stocks to buy now. On December 15, JPMorgan lowered its price target on Tempus AI, Inc. (NASDAQ:TEM) from $85 to $80. The firm maintained ...
Tempus AI has EV/forward revenue under 10x, positive EBITDA, 33% genomics growth, and $150M in new contracts. Find out why ...
Tempus AI Inc (NASDAQ:TEM) shares are moving higher Monday after the company introduced a new program to monitor immunotherapy response for patients with advanced cancer. What Happened: Tempus has ...
CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced the beta launch of a ...
CHICAGO, April 29, 2025--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced publication of ...
Zacks Investment Research on MSN
Tempus AI turns non-GAAP profit on surging genomics and data
Tempus AI TEM reported non-GAAP profit in the third quarter of 2025 as genomics testing and data services gained momentum. The stock carries a Zacks Rank #3 (Hold) with a VGM Score of D. It is weak on ...
Tempus, a genomic testing and data analysis company started by Eric Lefkofsky, who previously founded Groupon, debuted on Nasdaq on Friday, rising about 15% on the opening. The company priced its IPO ...
Tempus AI is a Buy for long-term growth, driven by its shift to a data/AI platform and accelerating genomics volume fueling high-margin revenue. Strategic deals (AstraZeneca/Pathos) and the Paige ...
CHICAGO--(BUSINESS WIRE)--Tempus, a leader in AI-enabled diagnostics, today unveiled a breakthrough technology for oncologists, Tempus ONE. This smart, voice-enabled, portable device brings Tempus’ ...
Although shares have retreated from their all-time high, those who bought shares one year ago are still looking at growth in their positions. While strong enthusiasm for artificial intelligence (AI) ...
CHICAGO, October 09, 2025--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced it has been selected by the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback